Cargando…
The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels
Background and purpose: Ivabradine is clinically administered to lower the heart rate, proposedly by inhibiting hyperpolarization-activated cyclic nucleotide-gated cation channels in the sinoatrial node. Recent evidence suggests that voltage-gated sodium channels (VGSC) are inhibited within the same...
Autores principales: | Hackl, Benjamin, Lukacs, Peter, Ebner, Janine, Pesti, Krisztina, Haechl, Nicholas, Földi, Mátyás C, Lilliu, Elena, Schicker, Klaus, Kubista, Helmut, Stary-Weinzinger, Anna, Hilber, Karlheinz, Mike, Arpad, Todt, Hannes, Koenig, Xaver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108390/ https://www.ncbi.nlm.nih.gov/pubmed/35586063 http://dx.doi.org/10.3389/fphar.2022.809802 |
Ejemplares similares
-
Evidence for a Physiological Role of T-Type Ca Channels in Ventricular Cardiomyocytes of Adult Mice
por: Marksteiner, Jessica, et al.
Publicado: (2022) -
Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy
por: Szabo, Petra Lujza, et al.
Publicado: (2023) -
Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel–Mediated Cardiotoxicity
por: Hackl, Benjamin, et al.
Publicado: (2021) -
Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart
por: Koenig, Xaver, et al.
Publicado: (2018) -
Distinct modulation of inactivation by a residue in the pore domain of voltage-gated Na(+) channels: mechanistic insights from recent crystal structures
por: Cervenka, Rene, et al.
Publicado: (2018)